In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.
Source: [New York Times](https://www.nytimes.com/2026/08/26/science/pancreatic-cancer-daraxonrasib-approval.html)
The health service in Northern Ireland currently faces a funding gap of £800m.
2 points, 1 comments on Hacker News
Patients taking the first-of-a-kind pill, called daraxonrasib, lived for a median of 13. 2 months compared with 6. 7 months for chemotherapy recipients, studies showed.
Anthony Edwards played a key part in recruiting Jonathan Kuminga
Dr. Danish Nagda, a shareholder in the developer, told Fortune it was "incredibly exciting ... maybe half a decade away from the post-cancer era.
The committee on health and family welfare has recommended that kidney transplant facilities be expanded to at least three govt medical colleges in large states and one in every small state and UT, besides setting time-bound targets to increase organ retrieval centres and transplant infrastructur...